Ascendis Pharma A (ASND) Invested Capital (2020 - 2026)
Ascendis Pharma A (ASND) posted Invested Capital of $864.8 million for Q1 2026, down 14.78% sequentially from $1.0 billion in Q4 2025, and down 25.94% YoY from $1.2 billion in Q1 2025.
Ascendis Pharma A (ASND) Invested Capital (2020 - 2026) Analysis & Trends
Ascendis Pharma A has reported Invested Capital for 7 years, with the latest figure at $864.8 million in Q1 2026.
- Quarterly Invested Capital fell 25.94% year-over-year to $864.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.4 billion (up 4.63% YoY) and the FY2025 annual result came in at $1.0 billion, up 10.86% from the prior year.
- Invested Capital declined to $864.8 million in Q1 2026 per ASND's latest filing, from $1.0 billion in the prior quarter.
- Over five years, Invested Capital peaked at $1.3 billion in Q3 2025 and troughed at $20.3 million in Q3 2022.
- A 5-year average of $761.2 million and a median of $834.6 million in 2023 frame the typical range for Invested Capital.
- The widest YoY moves for Invested Capital: up 4018.94% in 2023, down 96.46% in 2023.
- Over 5 years, Invested Capital stood at $518.7 million in 2022, then surged by 33.65% to $693.2 million in 2023, then jumped by 32.05% to $915.4 million in 2024, then advanced by 10.86% to $1.0 billion in 2025, then decreased by 14.78% to $864.8 million in 2026.
- According to Business Quant data, Invested Capital over the past three periods registered $864.8 million, $1.0 billion, and $1.3 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 190.90 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 2.57 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 380.00 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Ascendis Pharma A | 15.40 Bn | 14.73 Bn | 268.20 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 864.78 Mn |
| Dec 31, 2025 | 1.01 Bn |
| Sep 30, 2025 | 1.32 Bn |
| Jun 30, 2025 | 1.22 Bn |
| Mar 31, 2025 | 1.17 Bn |
| Dec 31, 2024 | 915.38 Mn |
| Sep 30, 2024 | 1.13 Bn |
| Jun 30, 2024 | 1.00 Bn |
| Mar 31, 2024 | 676.02 Mn |
| Dec 31, 2023 | 693.19 Mn |
| Sep 30, 2023 | 834.59 Mn |
| Jun 30, 2023 | 28.93 Mn |
| Mar 31, 2023 | 27.26 Mn |
| Dec 31, 2022 | 518.67 Mn |
| Sep 30, 2022 | 20.26 Mn |
| Jun 30, 2022 | 735.44 Mn |
| Mar 31, 2022 | 769.61 Mn |
| Dec 31, 2021 | 120.07 Mn |
| Dec 31, 2020 | 109.66 Mn |